Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2024-08-07 00:00:00 ET · period of report 2024-08-05 · accession 0001773751-24-000253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-07 | 2024-08-05 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $2.43 | +188.9K | 222.4K | +564% | +$459.0K |
| DMI | 2024-08-07 | 2024-08-05 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $16.57 | -144.4K | 890.0K | -14% | -$2.39M |
| DM | 2024-08-07 | 2024-08-05 | HIMS | Dudum Andrew | CEO, Dir, 10% | S - Sale+OE | $16.47 | -188.9K | 222.3K | -46% | -$3.11M |
| D | 2024-08-07 | 2024-08-05 | HIMS | Dudum Andrew | CEO, Dir, 10% | M - OptEx | $0.00 | -188.9K | 770.7K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-08-05 | M | A | 188,888 | $2.43 | 222,390 | D Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 | — | — | |
| 2 | Common | Class A Common Stock | 2024-08-05 | S | D | 12,903 | $16.97 | 939,934 | I | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.86 - $17.055. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. (F6) This amount reflects an annuity -in-kind transfer of 62,844 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD GRAT 2022. |
| 3 | Common | Class A Common Stock | 2024-08-05 | S | D | 131,541 | $16.53 | 889,993 | I | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.86 - $16.85. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Class A Common Stock | 2024-08-05 | S | D | 94,444 | $16.47 | 33,502 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.87 - $16.83. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Class A Common Stock | 2024-08-05 | S | D | 94,344 | $16.47 | 127,946 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.87 - $16.85. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Class A Common Stock | 2024-08-05 | S | D | 100 | $16.87 | 222,290 | D Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2024-08-05 | M | D | 188,888 | $0.00 | 770,680 | D | $2.43 · — to 2030-06-17 | 188,888 Class A Common Stock | (F7) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. |